Advanced Enzyme Technologies Ltd Quarterly Results
Q4 FY25-26 Results Summary
Revenue
The revenue stands at ₹203.37 crore, reflecting a quarter-on-quarter *(QoQ) increase of 18.27 per cent from ₹171.95 crore. This corresponds to a year-on-year *(YoY) growth of 21.65 per cent.
Operating Profit
Operating Profit stands at ₹63.23 crore, reflecting a quarter-on-quarter *(QoQ) increase of 28.13 per cent from ₹49.35 crore. This corresponds to a year-on-year *(YoY) growth of 38.66 per cent.
PBDT
PBDT stands at ₹69.99 crore, reflecting a quarter-on-quarter *(QoQ) increase of 2.18 per cent from ₹68.50 crore. This corresponds to a year-on-year *(YoY) growth of 30.72 per cent.
Profit Before Tax
Profit Before Tax stands at ₹59.80 crore, reflecting a quarter-on-quarter *(QoQ) increase of 2.59 per cent from ₹58.29 crore. This corresponds to a year-on-year *(YoY) growth of 37.60 per cent.
Net Profit
Net Profit stands at ₹45.25 crore, reflecting a quarter-on-quarter *(QoQ) increase of 4.79 per cent from ₹43.18 crore. This represents a 69.29 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Market News
Advanced Enzyme Technologies Ltd Earnings
- YOY
- QOQ
Advanced Enzyme Technologies Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Advanced Enzyme Technologies Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Advanced Enzyme Technologies Ltd Financial Reports
Advanced Enzyme Technologies Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Advanced Enzyme | 2.17% | -0.59% | 1.73% | 34.88% | 21.28% | 9.86% |
| Orchid Pharma | 9.72% | 6.70% | 28.59% | 81.71% | 10.50% | 30.11% |
| Bliss GVS Pharma | 0.47% | 4.17% | 52.83% | 117.26% | 204.98% | 197.42% |
| Guj. Themis Bio. | 2.44% | -3.50% | 11.51% | 39.74% | -0.93% | 10.90% |
| IOL Chemicals | 4.60% | 1.02% | 24.03% | 96.01% | 64.14% | 50.89% |
| Gufic BioScience | 6.09% | -4.29% | 33.11% | 31.22% | 5.65% | 0.18% |
| RPG LifeScience. | 0.80% | 5.50% | -3.54% | 17.25% | -4.21% | -8.10% |
Company Info
Company Information
Whole-time director : MUKUND MADHUSUDAN KABRA
Chairman (Non-Executive) : VASANT RATHI
Independent Director : Pramod Kasat
Company Sec. & Compli. Officer : Sanjay Basantani
Non-Executive & Non-Independent Director : Rasika Rathi
Independent Director : Vindokumar Hiralal Jajoo
Non-Executive & Non-Independent Director : Sunny Sharma
Independent Director : Rajshree Patel
Independent Director : NITIN JAGANNATH DESHMUKH
Independent Director : Vandana Tilak.